Findings of a recently published two-part study demonstrate that InterACT Rx™ can significantly enhance diagnosis and treatment of DDIs, improving...
Studies show an alarming prevalence of concurrent ingestion of interacting substances by patients and that providing physicians with clear, objective...
Nashville, Tennessee (Nov. 5, 2018) - Aegis Sciences Corporation is pleased to announce definitive testing for kratom (mitragynine) via liquid chromatography-...
Employing a definitive test to detect substances whose interactions may cause adverse drug events can enhance a provider’s insights, drive clinical...
InterACT Rx™ identified at least one drug-drug interaction (DDI) between recently ingested substances in as many as 20% of patients. Nashville,...
AcuRiseID™ is a new urinalysis that monitors medication adherence in people with mental illness and substance abuse disorder Nashville, Tennessee (Sept....
Sign up for the Aegis Newsletter